Invasive species cost trillions in damages: study
Since 1960, damage from non-native plants and animals expanding into new territory has cost society more than $2.2 trillion, 17 times higher than previous estimates, they reported in the journal Nature Ecology & Evolution.
The accelerating spread of invasive species -- from mosquitoes to wild boar to tough-to-eradicate plants -- blights agriculture, spreads disease and drives the growing pace of species extinction.
Earlier calculations based on highly incomplete data were already known to fall far short of reality.
To piece together a more accurate picture, an international team of researchers led by Ismael Soto, a scientist at the University of South Bohemia in the Czech Republic, compiled data on 162 invasive species whose costs have been well documented in at least a handful of countries.
They then modelled the economic impact for 78 other countries such as Bangladesh and Costa Rica, for which no data was previously available.
"We expected an underestimation of invasion costs, but the magnitude was striking," Soto told AFP.
Due mainly to high volumes of trade and travel, tens of thousands of animal and plant species have taken root, sometimes literally, far from their places of origin.
Europe is by far the continent most affected by the phenomenon, followed by North America and Asia.
"Plants were the most economically damaging group, both for damage and management," Soto said. "Cost hotspots include urban coastal areas, notably in Europe, eastern China, and the US."
Animals can cause devastating damage too.
Wild boar, for example, destroy crops, cornfields and vineyards, while mosquitoes -- with expanding ranges due to global warming -- impose direct costs to human health by spreading diseases such as dengue and malaria.
Another example is Japanese knotweed, an invasive plant that is very common in Europe and requires costly eradication programmes.
"Our study is based on only 162 species," Soto noted. "Our figure is probably still an underestimate of a wider problem, and therefore the real economic costs could be even higher."
Using a broader definition -- including indirect costs such as lost income -- the UN's biodiversity expert group, IPBES, has calculated the total cost to society of invasive species at about $400 billion annually.
jmi/mh/klm/jhb
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
5 hours ago
- Associated Press
Scientists get a rare peek inside of an exploding star
NEW YORK (AP) — Scientists for the first time have spotted the insides of a dying star as it exploded, offering a rare peek into stellar evolution. Stars can live for millions to trillions of years until they run out of fuel. The most massive ones go out with a bang in an explosion called a supernova. Using telescopes that peer deep into space, researchers have observed many such explosions. The cosmic outbursts tend to jumble up a dying star's layers, making it hard for scientists to observe the inner structure. But that wasn't the case for the new discovery, a supernova called 2021yfj located in our Milky Way galaxy. The collapsing star's outermost layers of hydrogen and helium had peeled away long ago, which wasn't surprising. But the star's dense, innermost layers of silicon and sulfur had also shed during the explosion. 'We have never observed a star that was stripped to this amount,' said Northwestern University's Steve Schulze, who was part of the discovery team that published the research Wednesday in the journal Nature. The finding lends evidence to ideas scientists have about how large stars look near the end of their lives, organized into layers with lighter elements on the outside and heavier ones close to the core. 'Because so many of the layers had been stripped off this star, this basically confirmed what those layers were,' said Anya Nugent, who studies supernovas at the Harvard-Smithsonian Center for Astrophysics. She was not involved with the new research. It's not yet clear how this star got so whittled down — whether its layers were flung off violently in the final stages of its life or yanked away by a twin star. Future research may yield clues, though scientists acknowledged such an event may be tough to capture again. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Yahoo
7 hours ago
- Yahoo
Experts make alarming discovery after analyzing species for over 2 decades: 'Evolution in action'
Experts make alarming discovery after analyzing species for over 2 decades: 'Evolution in action' Overfishing in the Bornholm Basin over the last several decades has made eastern Baltic cod shrink in size. What's happening? As Mongabay observed, a June 2025 study by GEOMAR stated that eastern Baltic cod have shrunk over time. Between 1996 and 2019, they lost about half their length and almost four-fifths of their typical weight. While fishing wasn't a variable tracked by the study, the researchers still believe it caused this rapid evolution to an extent. Trawling companies were only allowed to catch fish over 14 inches long to protect juvenile fish. But as of 2019, trawling has been banned. The study, published in the journal Science Advances, looked at the DNA of the fish to confirm this change. Researchers found that the gene patterns of smaller fish have become more common over time. "What we are observing is evolution in action, driven by human activity," said Professor Dr. Thorsten Reusch, one of the study's co-authors, in a press release. "This is scientifically fascinating, but ecologically deeply concerning." Why is overfishing concerning? Overfishing can severely damage our food supply chains and our ecosystems. According to the World Wildlife Fund, the global fishing industry is worth about $362 billion. If we continue to overfish, people will lose their jobs and sources of income. Overfishing exploits coastal economies and causes financial instability. It also threatens the survival of many marine animals. When overfishing takes fish out of the equation, that creates an imbalance within marine ecosystems. It could also lead to severely endangered species like the vaquita porpoise and Maui's dolphin going fully extinct. Do you think your city has good air quality? Definitely Somewhat Depends on the time of year Not at all Click your choice to see results and speak your mind. What's being done about overfishing? The banning of trawling in 2019 demonstrates the importance and value of taking action and spreading the word about environmentally harmful practices. It may take a long time to reverse the damage done to eastern Baltic cod, but researchers hope the tides will change for these fish. "That's why a paper like this is so important," David Conover, a professor emeritus in biology at the University of Oregon and a co-author of a related 2019 study, told Mongabay. "It's going to up the dialogue and increase conversations in the management community." Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet. Solve the daily Crossword
Business Wire
8 hours ago
- Business Wire
ClearStrand-ASD, First-of-Its-Kind Autism Screening Tool, Now Available in Japan
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)-- LinusBio, a leader in precision exposome medicine, announced today that ClearStrand-ASD™, its biochemical autism screening test, is now available to patients and providers in Japan for research use through its partnership with YAC Bio. This milestone marks LinusBio's first international expansion and represents a significant step in the company's mission to enable earlier identification of autism spectrum disorder (ASD) globally. Today marks a transformational moment in our mission to make early autism screening accessible worldwide. Share ClearStrand-ASD requires only a strand of hair to detect molecular signatures associated with autism spectrum disorder. This innovative, non-invasive approach provides healthcare providers with an objective screening method that can help identify ASD risk as early as one month of age, allowing families to pursue intervention during the most crucial period of early development. "Today marks a transformational moment in our mission to make early autism screening accessible worldwide," said Dr. Manish Arora, Founder and CEO of LinusBio. "Japan represents our first step beyond U.S. borders, and we chose this market because of its sophisticated healthcare infrastructure and commitment to pediatric developmental care. Japanese families dealing with autism concerns will now have access to the same cutting-edge screening technology that has already helped multiple American families get answers earlier than ever before." The Japanese launch builds on ClearStrand-ASD's successful rollout across the United States, where it is now available in 49 states. YAC Bio will partner with hospital systems in Japan to facilitate the implementation of this first-of-its-kind biomarker test for autism. LinusBio's expansion into Japan is facilitated through its existing partnership with YAC Bio (part of Y.A.C. Holdings), the Japanese multinational that invested over 1 billion yen in the company. Beyond providing market access, Y.A.C. Holdings contributes manufacturing expertise and automation capabilities that support LinusBio's scaling efforts globally. "By combining the world's only hair-cutting robotics technology with the innovative hair exposome analysis developed by LinusBio in the United States, we have contributed to the development of the world's first biomarker screening test for autism spectrum disorder. Following its launch in the U.S., we are now offering this test in Japan through our group company, YAC Bio," said Takefumi Momose, President and CEO, Y.A.C. Holdings Co., Ltd. "We sincerely hope that this test will support individuals, families, and communities in Japan who are concerned about autism." The Japan availability of ClearStrand-ASD represents the first phase of LinusBio's international expansion strategy, with the company evaluating additional markets where ClearStrand-ASD could address unmet needs in early autism detection. About ClearStrand-ASD ClearStrand-ASD is a biochemical test intended to help health care providers rule out autism spectrum disorder (ASD) in children 1 to 48 months. The test analyzes a strand of hair to map the dynamic patterns of an individual's unique biological responses at a molecular level to environmental exposures over time and uses an algorithm to assess the likelihood of autism. It is not a genetic test and must be ordered by a licensed health care provider (Rx only). ClearStrand-ASD is performed at LinusBio's CLIA-certified laboratory (CLIA #31d2307499). For more information visit: About LinusBio LinusBio (Linus Biotechnology Inc.) is a patient-centric, breakthrough science precision exposome medicine company headquartered in New Jersey. The Company's program pipeline comprises precision exposome medicine biomarkers and target discovery across disease domains for which historically no molecular endpoints have been available in medical practice or for clinical trials, including CNS (autism spectrum disorder, amyotrophic lateral sclerosis), gastroenterology (inflammatory bowel disease), renal disease and oncology. LinusBio is actively exploring additional international partnerships to expand global access to its innovative diagnostic solutions. For more information, visit About Y.A.C. Holdings Y.A.C. Holdings is a Japan-based company specializing in developing, designing, and manufacturing mechatronics-related products. The company collaborates with LinusBio on hardware innovations to scale testing capacity, driving breakthroughs in robotics and laboratory automation.
